David Liebowitz
Impact in
- Oncology top 2%
- Viral-associated cancers and disorders
- CAR-T cell therapy research
-
- Lymphoma Diagnosis and Treatment
Papers in ⓘ
- Oncology 13
- Viral-associated cancers and disorders 6
- CAR-T cell therapy research 5
-
- Lymphoma Diagnosis and Treatment 6
- Co-authors
- Elliott Kieff (3 shared papers)David Wang (1 shared paper)Everett E. Vokes (2 shared papers)Ralph R. Weichselbaum (1 shared paper)Sean N. Tucker (5 shared papers)Shaily Garg (3 shared papers)Walter M. Stadler (2 shared papers)Nicholas J. Vogelzang (1 shared paper)
- Journals
- Blood (3 papers)Genes Chromosomes and Cancer (2 papers)The Lancet Infectious Diseases (2 papers)Journal of Clinical Oncology (2 papers)Cell Host & Microbe (1 paper)
- Partner nations
- United StatesFranceAustralia
In The Last Decade
David Liebowitz
20 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Oncology 1.6k
- Pathology and Forensic Medicine 751
- Infectious Diseases 533
- Otorhinolaryngology 118
- Immunology 479
Countries citing papers authored by David Liebowitz
This map shows the geographic impact of David Liebowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Liebowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Liebowitz more than expected).
Fields of papers citing papers by David Liebowitz
This network shows the impact of papers produced by David Liebowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Liebowitz. The network helps show where David Liebowitz may publish in the future.
Co-authors
The 25 scholars most cited alongside David Liebowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells Hit paper breakdown → | 1985 | 1060 |
| 2 | 1997 | 196 | |
| 3 | 1998 | 179 | |
| 4 | 2000 | 167 | |
| 5 | 2003 | 153 | |
| 6 | 2018 | 100 | |
| 7 | 2020 | 87 | |
| 8 | 2015 | 66 | |
| 9 | 1987 | 46 | |
| 10 | 1999 | 46 | |
| 11 | 1998 | 43 | |
| 12 | 2000 | 40 | |
| 13 | 1999 | 25 | |
| 14 | 2019 | 24 | |
| 15 | 2021 | 23 | |
| 16 | 2021 | 19 | |
| 17 | 2022 | 8 | |
| 18 | 2021 | 5 | |
| 19 | 2018 | 4 | |
| 20 | 1989 | 2 |
About David Liebowitz
David Liebowitz is a scholar working on Oncology, Pathology and Forensic Medicine, Immunology, Epidemiology and Infectious Diseases, having authored 22 papers that have together received 2.3k indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (6 papers), Lymphoma Diagnosis and Treatment (6 papers), CAR-T cell therapy research (5 papers), Influenza Virus Research Studies (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Respiratory viral infections research (3 papers), Virus-based gene therapy research (2 papers) and Biosimilars and Bioanalytical Methods (2 papers). The work is most often cited by research in Oncology (1.6k citations), Pathology and Forensic Medicine (751 citations), Infectious Diseases (533 citations), Otorhinolaryngology (118 citations) and Immunology (479 citations). David Liebowitz has collaborated with scholars based in United States, France and Australia. Frequent co-authors include Elliott Kieff, David Wang, Everett E. Vokes, Ralph R. Weichselbaum, Sean N. Tucker, Shaily Garg, Walter M. Stadler, Nicholas J. Vogelzang, Jeffery A. Sosman and Robert J. Amato. Their work appears in journals such as Blood, Genes Chromosomes and Cancer, The Lancet Infectious Diseases, Journal of Clinical Oncology and Cell Host & Microbe.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.